Cargando…

Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy

Assessment of muscle pathology is a key outcome measure to measure the success of clinical trials studying muscular dystrophies; however, few robust minimally invasive measures exist. Indocyanine green (ICG)-enhanced near-infrared (NIR) optical imaging offers an objective, minimally invasive, and lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chrzanowski, Stephen M., Vohra, Ravneet S., Lee-McMullen, Brittany A., Batra, Abhinandan, Spradlin, Ray A., Morales, Jazmine, Forbes, Sean, Vandenborne, Krista, Barton, Elisabeth R., Walter, Glenn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985549/ https://www.ncbi.nlm.nih.gov/pubmed/29271299 http://dx.doi.org/10.1177/1536012117732439

Ejemplares similares

Magnetic Resonance Assessment of Hypertrophic and Pseudo-Hypertrophic Changes in Lower Leg Muscles of Boys with Duchenne Muscular Dystrophy and Their Relationship to Functional Measurements
por: Vohra, Ravneet S., et al.
Publicado: (2015)

Effect of uphill running on myocardium T(2) in mdx mice
por: Forbes, Sean C, et al.
Publicado: (2012)

Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging
por: Batra, Abhinandan, et al.
Publicado: (2022)

Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy
por: Willcocks, Rebecca J., et al.
Publicado: (2021)

Magnetic Resonance Imaging Is Sensitive to Pathological Amelioration in a Model for Laminin-Deficient Congenital Muscular Dystrophy (MDC1A)
por: Vohra, Ravneet, et al.
Publicado: (2015)

Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health
por: Bendixen, Roxanna M, et al.
Publicado: (2012)

Suitability of external controls for drug evaluation in Duchenne muscular dystrophy
por: Goemans, Nathalie, et al.
Publicado: (2020)

(13)C NMR Metabolomics: Applications at Natural Abundance
por: Clendinen, Chaevien S., et al.
Publicado: (2014)

Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy
por: Barnard, Alison M., et al.
Publicado: (2018)

(13)C/(31)P MRS Metabolic Biomarkers of Disease Progression and Response to AAV Delivery of hGAA in a Mouse Model of Pompe Disease
por: Baligand, Celine, et al.
Publicado: (2017)

Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy
por: Sugihara, Hidetoshi, et al.
Publicado: (2020)

Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials
por: Kim, Sarah, et al.
Publicado: (2023)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study
por: Forbes, Sean C., et al.
Publicado: (2014)

A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy
por: Victor, Ronald G., et al.
Publicado: (2017)

Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study
por: Comi, Giacomo P., et al.
Publicado: (2023)

Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy
por: Finanger, Erika, et al.
Publicado: (2019)

Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
por: Larkindale, Jane, et al.
Publicado: (2017)

Characterization of patients with Becker muscular dystrophy by histology, magnetic resonance imaging, function, and strength assessments
por: Comi, Giacomo P., et al.
Publicado: (2021)

Restless leg syndrome exacerbated by amytriptiline in a patient with Duchenne Muscular Dystrophy
por: Akamine, Ricardo Tera, et al.
Publicado: (2014)

MRI quantifies neuromuscular disease progression
por: Forbes, Sean C, et al.
Publicado: (2015)

The ties that bind: functional clusters in limb-girdle muscular dystrophy
por: Barton, Elisabeth R., et al.
Publicado: (2020)

Studies of pseudohypertrophic muscular dystrophy
por: Bonsett, Charles A., 1921-
Publicado: (1969)

Emery‐Dreifuss muscular dystrophy
por: Heller, Scott A., et al.
Publicado: (2019)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Differential Diagnosis between Duchenne Muscular Dystrophy and Limb Girdle Muscular Dystrophy 2a
por: DOBRESCU, M.A., et al.
Publicado: (2015)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy
por: Burakiewicz, Jedrzej, et al.
Publicado: (2017)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

Mechanisms of muscle weakness in muscular dystrophy
por: Goldstein, Jeffery A., et al.
Publicado: (2010)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
por: Milad, Nadia, et al.
Publicado: (2017)

Gene transfer of arginine kinase to skeletal muscle using adeno-associated virus
por: Forbes, Sean C., et al.
Publicado: (2014)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies
por: Rawls, Alan, et al.
Publicado: (2023)

Autonomic regulation in muscular dystrophy
por: Angelini, Corrado, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kan1g8asf6r9cjbc872cijj4qc